Thank you for your interest in the Xalt2 clinical research study.

This study is evaluating an investigational medication for ALK positive non-small cell lung cancer (NSCLC).

To see if you may be eligible, you will be asked a few questions.

If you pre-qualify, the information you provide will be shared with the study site conducting the study.

Your privacy and personal information will always be protected.

To learn more, please read our privacy policy.




Loading